SHAREHOLDERS’ DEFICIT | NOTE 8 – SHAREHOLDERS’ DEFICIT Preferred Stock Series A Preferred Stock Attributes of Series A Preferred Stock include but are not limited to the following: Distribution in Liquidation The Series A Preferred Stock has a liquidation preference of $10,000,000, payable only upon certain liquidity events or upon achievement of a market value of our equity equalling $200,000,000 or more. Upon any liquidation, dissolution or winding up of the Company, and after paying or adequately providing for the payment of all its obligations, the remainder of the assets of the Company shall be distributed, either in cash or in kind, first pro rata to the holders of the Series A Preferred Stock in an amount equal to the Liquidation Value (as described below); then, to any other series of Preferred Stock, until an amount to be determined by a resolution of the Board of Directors prior to issuances of such Preferred Stock, has been distributed per share, and, then, the remainder pro rata to the holders of the Common Stock. Upon the occurrence of any Liquidation Event (as defined below), each holder of Series A Preferred Stock will receive a payment equal to the Original Issue Price for each share of Series A Preferred Stock held by such holder (the “Liquidation Value”). A “Liquidation Event” will have occurred when: ● The Company has an average market capitalization (calculated by adding the value of all outstanding shares of Common Stock valued at the Company’s closing sale price on the OTC Market or other applicable bulletin board or exchange, plus the value of the outstanding Series A Preferred Stock at the Original Issues Price per share) of $200,000,000 or more over any 90 day period. The holders of the Series A Preferred Stock would have the right, for 30 days after the end of such qualifying 90 day measurement period, to require the Company to purchase the Series A Preferred Stock for an amount equal to the Liquidation Value. ● Any Liquidity Event in which the Company receives proceeds of $50,000,000 or more. For purposes hereof, a “Liquidity Event” means any (a) liquidation, dissolution or winding up of the Company; (b) acquisition of the Company by means of any transaction or series of related transactions (including, without limitation, any reorganization, merger, share exchange, share purchase or consolidation) provided that the applicable transaction shall not be deemed a liquidation unless the Company’s stockholders constituted immediately prior to such transaction hold less than 50% of the voting power of the surviving or acquiring entity; or (c) the sale, lease, transfer or other disposition, in a single transaction or series of related transactions, by the Company or any subsidiary of the Company of all or substantially all the assets of the Company and its subsidiaries taken as a whole, or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the Company if substantially all of the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries. Written notice of any Liquidation Event (the “Liquidation Notice”) shall be given by mail, postage prepaid, or by facsimile to non-U.S. residents, not less than five days prior to the anticipated payment date state therein, to the holders of record of Series A Preferred Stock, such notice to be addressed to each such holder at its address as shown by the records of the Company. The Liquidation Notice shall state (i) the anticipated payment date, and (ii) the total Liquidation Value available for distribution to Series A Preferred Stock shareholders upon the occurrence of the Liquidation Event. Redemption The Series A Preferred Stock may be redeemed in whole or in part as determined by a resolution of the Board of Directors at any time, at a price equal to the Liquidation Value. Voting Rights Shares of Series A Preferred Stock shall have no rights to vote on any matter submitted to a vote of shareholders, except as required by law, in which case each share of Series A Preferred Stock shall be entitled to one vote. Conversion Rights Holders of Series A Preferred Stock will have no right to convert such shares into any other equity securities of the Company. Common Stock Common Stock issued on exercise of stock option During the year ending December 31, 2020, options on 2,750,000 and warrants on 1,882,920 restricted common shares were exercised at an approved reduced conversion price of $0.023, based upon market conditions. Of the options and warrants exercised 2,750,000 options and 1,882,920 warrants were modified as to exercise date resulting in a loss on modification of $115,722. On December 21, 2019, a convertible promissory note payable totalling $192,080 was exchanged as consideration for exercising a stock option for 4,500,000 restricted common shares at an approved reduced conversion price of $0.0426, which was the market price on exercise. Sale of Common Stock None. Option Grants The following tables summarize information about the Company’s stock options: Number of Weighted Average Exercise Price Options outstanding - December 31, 2018 32,576,223 $ 0.98 Granted — — Cancelled or expired --- --- Exercised 4,500,000 1.07 Options outstanding - December 31, 2019 28,076,223 $ 1.07 Granted — — Cancelled or expired 22,076,223 0.95 Exercised 2,750,000 0.92 Options outstanding - December 31, 2020 3,250,000 $ 1.07 There are no unvested options as of December 31, 2020. The following tables summarize information about stock options outstanding and exercisable: Options Outstanding and Exercisable at December 31, 2020 Range of Number Outstanding Weighted Remaining Contractual Life Weighted Average Exercise Price Aggregate Intrinsic $0.40 to $0.60 --- $ --- $ — $0.61 to $1.00 --- --- $ --- $ — $1.01 to $1.50 1,000,000 .0 years $ 1.25 $ — $1.51 to $2.25 2,250,000 .25 years $ 1.93 $ — $0.40 to $2.25 3,250,000 .2 years $ 1.07 $ — Options Outstanding and Exercisable at December 31, 2019 Range of Number Exercisable Weighted Remaining Contractual Life Weighted Average Exercise Price Aggregate Intrinsic $0.40 to $0.60 776,223 .8 years $ 0.60 $ — $0.61 to $1.00 9,800,000 .7 years $ 0.67 $ — $1.01 to $1.50 14,500,000 .8 years $ 1.25 $ — $1.51 to $2.25 3,000,000 1.3 years $ 1.63 $ — $0.40 to $2.25 28,076,223 .9 years $ 1.07 $ — (1) The aggregate intrinsic value in the table represents the difference between the closing stock price on December 31, 2020 and 2019 and the exercise price, multiplied by the number of in-the-money options that would have been received by the option holders had all option holders exercised their options on December 31, 2020 and 2019. Common Stock Purchase Warrants For warrants granted to non-employees in exchange for services, the Company recorded the fair value of the equity instrument using the Black-Scholes pricing model unless the value of the services is more reliably measurable. The following table summarizes information about the Company’s stock purchase warrants outstanding and exercisable at December 31, 2020 and December 31, 2019: Number Weighted Average Exercise Price Range of Exercise Price Weighted Remaining Contractual Life Outstanding at December 31, 2018 4,865,640 $ 0.84 $ 0.20 – 1.23 1.5 years Granted — Cancelled or expired --- Exercised --- Outstanding at December 31, 2019 4,865,640 $ 0.84 $ 0.20 – 1.23 .5 years Granted --- Cancelled or expired 2,732,720 0.76 $ 0.20 – 0.89 --- Exercised 1,882,920 0.89 0.89 --- Warrants exercisable at December 31, 2020 250,000 $ 1.23 $ 1.23 1.2 years The aggregate intrinsic value of the 250,000 and 4,865,640 outstanding and exercisable warrants at December 31, 2020 and 2019, respectively, was $0. The intrinsic value is the difference between the closing stock price on December 31, 2020 and 2019 and the exercise price, multiplied by the number of in-the-money warrants had all warrant holders exercised their warrants on December 31, 2020 and 2019. |